FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q31129235> ?p ?o ?g. }

• Q31129235 description "2016 nî lūn-bûn" @default.
• Q31129235 description "2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած" @default.
• Q31129235 description "2016 թվականի օգոստոսին հրատարակված գիտական հոդված" @default.
• Q31129235 description "2016年の論文" @default.
• Q31129235 description "2016年論文" @default.
• Q31129235 description "2016年論文" @default.
• Q31129235 description "2016年論文" @default.
• Q31129235 description "2016年論文" @default.
• Q31129235 description "2016年論文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016年论文" @default.
• Q31129235 description "2016년 논문" @default.
• Q31129235 description "article científic" @default.
• Q31129235 description "article scientific" @default.
• Q31129235 description "article scientifique (publié 2016)" @default.
• Q31129235 description "articol științific" @default.
• Q31129235 description "articolo scientifico" @default.
• Q31129235 description "artigo científico (publicado na 2016)" @default.
• Q31129235 description "artigo científico (publicado na 2016)" @default.
• Q31129235 description "artigo científico" @default.
• Q31129235 description "artikull shkencor" @default.
• Q31129235 description "artikulong pang-agham" @default.
• Q31129235 description "artykuł naukowy" @default.
• Q31129235 description "artículo científico publicado en 2016" @default.
• Q31129235 description "artículu científicu espublizáu en 2016" @default.
• Q31129235 description "bilimsel makale" @default.
• Q31129235 description "bài báo khoa học" @default.
• Q31129235 description "mokslinis straipsnis" @default.
• Q31129235 description "naučni članak" @default.
• Q31129235 description "scienca artikolo" @default.
• Q31129235 description "scientific article" @default.
• Q31129235 description "teaduslik artikkel" @default.
• Q31129235 description "tieteellinen artikkeli" @default.
• Q31129235 description "tudományos cikk" @default.
• Q31129235 description "vedecký článok" @default.
• Q31129235 description "vetenskaplig artikel" @default.
• Q31129235 description "videnskabelig artikel (udgivet 2016)" @default.
• Q31129235 description "vitenskapelig artikkel" @default.
• Q31129235 description "vitskapeleg artikkel" @default.
• Q31129235 description "vědecký článek" @default.
• Q31129235 description "wetenschappelijk artikel" @default.
• Q31129235 description "wissenschaftlicher Artikel" @default.
• Q31129235 description "επιστημονικό άρθρο" @default.
• Q31129235 description "мақолаи илмӣ" @default.
• Q31129235 description "мақолаи илмӣ" @default.
• Q31129235 description "наукова стаття, опублікована в серпні 2016" @default.
• Q31129235 description "научна статия" @default.
• Q31129235 description "научная статья" @default.
• Q31129235 description "научни чланак" @default.
• Q31129235 description "научни чланак" @default.
• Q31129235 description "מאמר מדעי" @default.
• Q31129235 description "سائنسی مضمون" @default.
• Q31129235 description "مقالة علمية (نشرت في 2-8-2016)" @default.
• Q31129235 description "مقالهٔ علمی" @default.
• Q31129235 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q31129235 description "บทความทางวิทยาศาสตร์" @default.
• Q31129235 description "სამეცნიერო სტატია" @default.
• Q31129235 name "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 name "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 name "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 type Item @default.
• Q31129235 label "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 label "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 label "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 prefLabel "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 prefLabel "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 prefLabel "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 P1433 Q31129235-0A90E8F7-9164-44B4-BD32-6C36CBC2AB3C @default.
• Q31129235 P1476 Q31129235-20A9A0C8-1D96-4C77-88DD-9CC449807A4D @default.
• Q31129235 P2093 Q31129235-10E0AD2B-E70C-4E27-8E9B-344ABCF79422 @default.
• Q31129235 P2093 Q31129235-2B8971B6-EFF1-4A2C-BE0D-30CB51FF6D6D @default.
• Q31129235 P2093 Q31129235-57E3D9C0-5024-41DF-BF06-3DC04652D978 @default.
• Q31129235 P2093 Q31129235-5885AB32-16F4-437F-B792-AF10D4652676 @default.
• Q31129235 P2093 Q31129235-6C6E7271-D7B6-444F-A32C-759A1090360E @default.
• Q31129235 P2093 Q31129235-7DF5D2E7-EDF7-499E-ADF2-CC114B7BBDEF @default.
• Q31129235 P2093 Q31129235-A04BBD2C-1867-4213-BB2E-A71197AFD9AF @default.
• Q31129235 P2093 Q31129235-A86D16F9-2168-4130-A47C-2F8A4727F7E9 @default.
• Q31129235 P2093 Q31129235-D000AA9A-C6F9-493E-9210-91C498BCDE2F @default.
• Q31129235 P2093 Q31129235-EB39C09A-5F58-4473-87FA-7AFF850B32FC @default.
• Q31129235 P304 Q31129235-C11C0647-CAB7-4297-A43A-F23CA5687E89 @default.
• Q31129235 P31 Q31129235-5028B853-6402-4B6F-9CDB-771013288A76 @default.
• Q31129235 P356 Q31129235-B64FCA81-52EB-4FD7-B6D2-0B5A89150173 @default.
• Q31129235 P433 Q31129235-CB6C89EA-AE14-4D69-852C-A59BD17FD133 @default.
• Q31129235 P478 Q31129235-FB3C70D1-800F-4B10-9331-E34C0D334A95 @default.
• Q31129235 P577 Q31129235-B3E75FA8-C828-4390-9811-53405DDB7909 @default.
• Q31129235 P698 Q31129235-ECA592A3-CBC1-4335-A3D9-CD958E6F0541 @default.
• Q31129235 P356 000448085 @default.
• Q31129235 P698 27614872 @default.
• Q31129235 P1433 Q26842274 @default.
• Q31129235 P1476 "Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)." @default.
• Q31129235 P2093 "Cornelia Kropf-Sanchen" @default.
• Q31129235 P2093 "Henrik Depenbrock" @default.
• Q31129235 P2093 "Jacqueline Brown" @default.
• Q31129235 P2093 "Jörg Mezger" @default.
• Q31129235 P2093 "Mark A Socinski" @default.
• Q31129235 P2093 "Martin Reck" @default.

• next